August 19, 2017 10:57 AM ET

Biotechnology

Company Overview of 480 Biomedical, Inc.

Key Executives for 480 Biomedical, Inc.

NameBoard RelationshipsTitleAge
Maria Palasis Ph.D.21 RelationshipsChief Executive Officer, President and Director--
Robert S. Langer Jr., Ph.D., Sc.D.557 RelationshipsCo-Founder and Director68
George M. Whitesides Ph.D.103 RelationshipsCo-Founder and Director78
Ray Knox No RelationshipsVice President of Operations--
Upma Sharma Ph.D.No RelationshipsSenior Director of Research & Development--

480 Biomedical, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Richard W. Mott 36 RelationshipsMicrochips Biotech, Inc.--
Maria Palasis Ph.D. 21 RelationshipsArsenal Medical, Inc.--
George M. Whitesides Ph.D. 103 RelationshipsNano Terra, Inc.78
Robert S. Langer Jr., Ph.D., Sc.D. 557 RelationshipsPureTech Health plc68
Carmichael S. Roberts Jr., Ph.D. 199 RelationshipsMC10, Inc.--
View All Board Members

480 Biomedical, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
387.2K
Bonus
237.8K
Total Short Term Compensation
481.5K
Total Value of Options
18.6M
Compensation as of Fiscal Year
480 Biomedical, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

RHS Limited Appoints Alwin Hui as Chief Commercial Officer
August 18, 2017 3:43 AM ET
Immunocellular Therapeutics, Ltd. Announces Resignation of Mark A. Schlossberg and Gregg A. Lapointe from the Board of Directors
August 17, 2017 8:32 PM ET
Five Prime Therapeutics, Inc. Appoints Bryan Irving as Senior Vice President, Research, with Effect from September 1, 2017
August 17, 2017 8:05 PM ET
BlueRock Therapeutics Expands Toronto Presence with R&D and Manufacturing Hub; Appoints Michael Scott as Senior Vice President of Product Development and Toronto Operations
August 17, 2017 12:00 PM ET
PsiOxus Therapeutics Announce Two New Board Members
August 17, 2017 7:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact 480 Biomedical, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.